# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-008664
Filing Date
2017-08-14
Accepted
2017-08-14 16:27:27
Documents
56
Period of Report
2017-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0617_immudyneinc.htm | 10-Q | 671521
2 | DIRECTOR AGREEMENT | f10q0617ex10i_immudyne.htm | EX-10.1 | 80556
3 | DIRECTOR AGREEMENT | f10q0617ex10ii_immudyne.htm | EX-10.2 | 76693
4 | SECOND AMENDMENT TO SERVICES AGREEMENT | f10q0617ex10iii_immudyne.htm | EX-10.3 | 19507
5 | EMPLOYMENT AGREEMENT WITH MARK MCLAUGHLIN, DATED JULY1, 2017 | f10q0617ex10iv_immudyneinc.htm | EX-10.4 | 62589
6 | DIRECTOR AGREEMENT WITH ANTHONY BRUZZESE, DATED JULY 1, 2017 | f10q0617ex10v_immudyneinc.htm | EX-10.5 | 81150
7 | DIRECTOR AGREEMENT WITH JOHN STRAWN, DATED JULY 1, 2017 | f10q0617ex10vi_immudyneinc.htm | EX-10.6 | 81518
8 | CERTIFICATION | f10q0617ex31i_immudyneinc.htm | EX-31.1 | 17408
9 | CERTIFICATION | f10q0617ex32i_immudyneinc.htm | EX-32.1 | 2968
| Complete submission text file | 0001213900-17-008664.txt |  | 4820739

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL INSTANCE FILE | immd-20170630.xml | EX-101.INS | 781452
11 | XBRL SCHEMA FILE | immd-20170630.xsd | EX-101.SCH | 40383
12 | XBRL CALCULATION FILE | immd-20170630_cal.xml | EX-101.CAL | 28758
13 | XBRL DEFINITION FILE | immd-20170630_def.xml | EX-101.DEF | 229119
14 | XBRL LABEL FILE | immd-20170630_lab.xml | EX-101.LAB | 424996
15 | XBRL PRESENTATION FILE | immd-20170630_pre.xml | EX-101.PRE | 318691

Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-184487 | Film No.: 171030608
SIC: 2833 Medicinal Chemicals & Botanical Products